These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3105957)

  • 21. Listeria monocytogenes endophthalmitis in a renal-transplant patient receiving ciclosporin.
    Algan M; Jonon B; George JL; Lion C; Kessler M; Burdin JC
    Ophthalmologica; 1990; 201(1):23-7. PubMed ID: 2118244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA; Aquino A; Ali A; Rodriguez R; Ali S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract]   [Full Text] [Related]  

  • 23. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
    Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
    Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose ciclosporin, prednisone, and azathioprine after initial immunosuppression with ciclosporin and prednisone in a pediatric renal transplant population.
    Turner MC
    Child Nephrol Urol; 1990; 10(3):125-30. PubMed ID: 2285916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum interleukin 2 activity in renal graft recipients.
    Sunder-Plassmann G; Stockenhuber F; Balcke P
    Transplant Proc; 1988 Jun; 20(3):387-9. PubMed ID: 3289167
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclosporine as treatment for corticosteroid-resistant rejection episodes in renal transplantation.
    Garcia VD; Goldani JC; Garcia CD; Cantisani GP; Losekann A; Messias A; Mattos DB; Vitola SP; Bianchini JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1643-5. PubMed ID: 2652537
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclosporine experience in renal transplantation in children.
    Tejani A; Butt KM; Khawar MR; Phadke K; Adamson O; Hong J; Fusi M; Trachtman H
    Kidney Int Suppl; 1986 Jul; 19():S38-43. PubMed ID: 3528624
    [No Abstract]   [Full Text] [Related]  

  • 28. Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation.
    Henry ML; Sommer BG; Ferguson RM
    Am J Surg; 1985 Nov; 150(5):533-6. PubMed ID: 2998215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of chronic rejection by cyclosporine and prednisone.
    Arnold AN; Anaise D; Miller F; Waltzer WC; Rapaport FT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2122-3. PubMed ID: 3274479
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical results of immunosuppression with cyclosporin A in cadaveric kidney transplantation].
    Madsen S; Kristensen JK; Langhoff E; Olgaard K; Ladefoged J; Thaysen JH
    Ugeskr Laeger; 1984 Mar; 146(13):951-4. PubMed ID: 6372185
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
    Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed graft function following cadaver renal transplantation in the cyclosporine era: analysis of acute rejection and graft survival.
    Bauma WD; Tang IY; Maddux MS; Veremis SA; Pollak R; Mozes MF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1276-7. PubMed ID: 2652422
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of immunosuppression on the prevalence of aseptic bone necrosis after renal transplantation.
    Cotorruelo JG; De Francisco AL; Canga E; Amado JA; Riancho JA; De Bonis E; Zubimendi JA; Ruiz JC; Sanz de Castro S; Arias M
    Transplant Proc; 1991 Aug; 23(4):2199-200. PubMed ID: 1871842
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of cyclosporine in pediatric renal transplant recipients.
    Conley SB; Flechner SM; Rose G; Van Buren CT; Brewer E; Kahan BD
    J Pediatr; 1985 Jan; 106(1):45-9. PubMed ID: 3880820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporin A in children with persistent renal transplant rejection and progressively deteriorating graft function.
    Geary DF; Thorner P; Baumal R; Major M; Arbus G
    Pediatr Nephrol; 1987 Apr; 1(2):140-4. PubMed ID: 3153270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
    Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of immunosuppressive problems in renal allograft recipients.
    Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1951-4. PubMed ID: 3547899
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporine in the treatment of acute allograft rejection refractory to high-dose methylprednisolone: results of a prospectively randomized trial.
    Margreiter R; Lang A; Koenig P; Kathrein H; Spielberger M; Steiner E; Huber C
    Transplant Proc; 1984 Oct; 16(5):1202-4. PubMed ID: 6385378
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prospective study of a triple immunosuppressive combination in renal transplantation: cyclosporin A-corticoids-azathioprine].
    Fries D; Kechrid C; Charpentier B; Hammouche M; Moulin B; Rieu P; Neyrat N; Bellamy J; Benoit G
    Presse Med; 1985 Dec; 14(45):2279-82. PubMed ID: 2935811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.